Answers are grounded in this paper and cite their sources.
Novel organoplatinum(II) complexes with 2-acetylthiophene thiosemicarbazone (ATTSC) were synthesized. The reaction of K 2 PtCl 4 with ATTSC in 1:1 and 1:2 metal to ligand ratios yielded 1 [Pt 4 (ATTSC-2H) 4 ·4DMF] and 2 [Pt(ATTSC-H)(ATTSC)Cl·3CH 3 OH)]. The crystal structures of these platinum chelates have been solved by single-crystal X-ray diffraction structure determinations and revealed metalation of the thiophene ring at C2 through platinum atoms. Further characterization of 1 and 2 was performed using electronic, IR, UV/vis, and NMR spectroscopies and elemental analysis. The in vitro antitumor activity of the ligand as well as 1 and 2 was determined against two different human tumor cell lines (HT-29 and HuTu-80). These tests revealed that the platinum(II) complexes are more cytotoxic than their ligand. The tetranuclear complex 1 shows higher antiproliferative activity (IC 50 = 1.2 and 1.5 μM) when compared to 2 (IC 50 = 3 and 5.9 μM), while the ligand has IC 50 values of 8.6 and >10 μM. Compounds 1 and 2 can therefore be considered as agents with potential antitumor activity.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: